BMRN

Biomarin Pharmaceutical Inc (BMRN)

US
$ 60.25-10.71%

Price Chart

Key Statistics

Market Cap
$ 11.22B
P/E Ratio
21.66
Revenue (TTM)
$ 2.95B
Volume
3.19M
52W High
$ 94.85
52W Low
$ 52.93
Dividend Yield
0.00%
Beta
0.27

Technicals

50-Day MA
63.696
200-Day MA
69.2389
52 Week High
94.85
52 Week Low
52.93

About BMRN

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Eur.

Employees
3040
Headquarters
San Rafael, CA
CEO
Mr. Alexander Hardy

Latest News

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
25.92
Percentile: 42.26
Environmental Risk Score
0.12
Percentile: 1
Social Risk Score
15.87
Percentile: 1
Governance Risk Score
7.42
Percentile: 1

Controversy Level

ESG data provided by Sustainalytics, Inc.

BMRN
Category Average
1Low Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
URBN
Urban Outfitters In...
$ 70.35
18.00
SNOW
Snowflake Inc. Clas...
$ 196.63
9.76
MNSO
MINISO Group Holdin...
$ 21.95
5.63
CLSK
CleanSpark Inc. Com...
$ 10.59
5.22
UAVS
AgEagle Aerial Syst...
$ 0.81
5.19

Top Losers

Symbol/Name
LTP
% Chg
FAST
Fastenal Company Co...
$ 41.43
-49.12
EDBL
Edible Garden AG In...
$ 4.60
-21.23
SEDG
SolarEdge Technolog...
$ 17.29
-12.76
ENPH
Enphase Energy Inc....
$ 42.32
-10.47
HIMS
Hims & Hers Health ...
$ 53.00
-8.57